Abstract:Alcohol consumption remains one of the predominant causes of liver disease and liver-related death worldwide. Intriguingly, dysregulation of the gut barrier is a key factor promoting the pathogenesis of alcoholic liver disease (ALD). A functional gut barrier, which consists of a mucus layer, an intact epithelial monolayer and mucosal immune cells, supports nutrient absorption and prevents bacterial penetration. Compromised gut barrier function is associated with the progression of ALD. Indeed, alcohol consumption disrupts the gut barrier, increases gut permeability, and induces bacterial translocation both in ALD patients and in experimental models with ALD. Moreover, alcohol consumption also causes enteric dysbiosis with both numerical and proportional perturbations. Here, we review and discuss mechanisms of alcohol-induced gut barrier dysfunction to better understand the contribution of the gut-liver axis to the pathogenesis of ALD. Unfortunately, there is no effectual Food and Drug Administration-approved treatment for any stage of ALD. Therefore, we conclude with a discussion of potential strategies aimed at restoring the gut barrier in ALD. The principle behind antibiotics, prebiotics, probiotics and fecal microbiota transplants is to restore microbial symbiosis and subsequently gut barrier function. Nutrient-based treatments, such as dietary supplementation with zinc, niacin or fatty acids, have been shown to regulate tight junction expression, reduce intestinal inflammation, and prevent endotoxemia as well as liver injury caused by alcohol in experimental settings. Interestingly, saturated fatty acids may also directly control the gut microbiome. In summary, clinical and experimental studies highlight the significance and efficacy of the gut barrier in treating ALD.

Targeting Inflammation for the Treatment of Alcoholic Liver Disease.

Noncoding RNAs in Alcoholic Liver Disease

New Drug Targets for Alcoholic Liver Disease

Alcohol and the mechanisms of liver disease

Role of Inflammatory Factors in Development and Progression of Alcoholic Liver Disease

Analysis of Differentially Expressed Genes and Micrornas in Alcoholic Liver Disease

Recent Advances in Understanding of Pathogenesis of Alcohol-Associated Liver Disease

New insights into the bile acid-based regulatory mechanisms and therapeutic perspectives in alcohol-related liver disease

Inflammation in Steatotic Liver Diseases: Pathogenesis and Therapeutic Targets

Alcoholic Hepatitis: A Review

Liver regeneration and alcoholic liver disease

Alcohol-Associated Liver Disease Outcomes: Critical Mechanisms of Liver Injury Progression

Recent Insights Into the Role of Immune Cells in Alcoholic Liver Disease

Myeloid Cells in Alcoholic Liver Diseases: Mechanism and Prospect

Critical Roles of Kupffer Cells in the Pathogenesis of Alcoholic Liver Disease: from Basic Science to Clinical Trials

Pathogenic mechanisms and regulatory factors involved in alcoholic liver disease

Natural compounds in the chemoprevention of alcoholic liver disease

The Beneficial Effects of Natural Extracts and Bioactive Compounds on the Gut-Liver Axis: A Promising Intervention for Alcoholic Liver Disease

Probiotics and Alcoholic Liver Disease: Treatment and Potential Mechanisms

Targeting the Gut Barrier for the Treatment of Alcoholic Liver Disease

Hepatic stellate cells and innate immunity in alcoholic liver disease